The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Shingles Treatments Market Research Report 2025
Synopsis
Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area.
The global Shingles Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Shingles Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shingles Treatments.
Report Scope
The Shingles Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Shingles Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Shingles Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma
Foamix
Novartis
Roche
GlaxoSmithKline
Epiphany Biosciences
Merck
Beijing Minhai Biotechnology
GeneOne Life Science
NAL Pharmaceuticals
TSRL
Segment by Type
Oral
Tablets
Segment by Application
Clinics
Hospitals
Diagnostic Centres
Home Care Settings
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Shingles Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area.
The global Shingles Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Shingles Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shingles Treatments.
Report Scope
The Shingles Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Shingles Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Shingles Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma
Foamix
Novartis
Roche
GlaxoSmithKline
Epiphany Biosciences
Merck
Beijing Minhai Biotechnology
GeneOne Life Science
NAL Pharmaceuticals
TSRL
Segment by Type
Oral
Tablets
Segment by Application
Clinics
Hospitals
Diagnostic Centres
Home Care Settings
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Shingles Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Shingles Treatments Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Shingles Treatments Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centres
1.3.5 Home Care Settings
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Shingles Treatments Market Perspective (2019-2030)
2.2 Shingles Treatments Growth Trends by Region
2.2.1 Global Shingles Treatments Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Shingles Treatments Historic Market Size by Region (2019-2024)
2.2.3 Shingles Treatments Forecasted Market Size by Region (2025-2030)
2.3 Shingles Treatments Market Dynamics
2.3.1 Shingles Treatments Industry Trends
2.3.2 Shingles Treatments Market Drivers
2.3.3 Shingles Treatments Market Challenges
2.3.4 Shingles Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Shingles Treatments Players by Revenue
3.1.1 Global Top Shingles Treatments Players by Revenue (2019-2024)
3.1.2 Global Shingles Treatments Revenue Market Share by Players (2019-2024)
3.2 Global Shingles Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Shingles Treatments Revenue
3.4 Global Shingles Treatments Market Concentration Ratio
3.4.1 Global Shingles Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Shingles Treatments Revenue in 2023
3.5 Shingles Treatments Key Players Head office and Area Served
3.6 Key Players Shingles Treatments Product Solution and Service
3.7 Date of Enter into Shingles Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Shingles Treatments Breakdown Data by Type
4.1 Global Shingles Treatments Historic Market Size by Type (2019-2024)
4.2 Global Shingles Treatments Forecasted Market Size by Type (2025-2030)
5 Shingles Treatments Breakdown Data by Application
5.1 Global Shingles Treatments Historic Market Size by Application (2019-2024)
5.2 Global Shingles Treatments Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Shingles Treatments Market Size (2019-2030)
6.2 North America Shingles Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Shingles Treatments Market Size by Country (2019-2024)
6.4 North America Shingles Treatments Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Shingles Treatments Market Size (2019-2030)
7.2 Europe Shingles Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Shingles Treatments Market Size by Country (2019-2024)
7.4 Europe Shingles Treatments Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Shingles Treatments Market Size (2019-2030)
8.2 Asia-Pacific Shingles Treatments Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Shingles Treatments Market Size by Region (2019-2024)
8.4 Asia-Pacific Shingles Treatments Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Shingles Treatments Market Size (2019-2030)
9.2 Latin America Shingles Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Shingles Treatments Market Size by Country (2019-2024)
9.4 Latin America Shingles Treatments Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Shingles Treatments Market Size (2019-2030)
10.2 Middle East & Africa Shingles Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Shingles Treatments Market Size by Country (2019-2024)
10.4 Middle East & Africa Shingles Treatments Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Shingles Treatments Introduction
11.1.4 Astellas Pharma Revenue in Shingles Treatments Business (2019-2024)
11.1.5 Astellas Pharma Recent Development
11.2 Foamix
11.2.1 Foamix Company Detail
11.2.2 Foamix Business Overview
11.2.3 Foamix Shingles Treatments Introduction
11.2.4 Foamix Revenue in Shingles Treatments Business (2019-2024)
11.2.5 Foamix Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Shingles Treatments Introduction
11.3.4 Novartis Revenue in Shingles Treatments Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Shingles Treatments Introduction
11.4.4 Roche Revenue in Shingles Treatments Business (2019-2024)
11.4.5 Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Shingles Treatments Introduction
11.5.4 GlaxoSmithKline Revenue in Shingles Treatments Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Epiphany Biosciences
11.6.1 Epiphany Biosciences Company Detail
11.6.2 Epiphany Biosciences Business Overview
11.6.3 Epiphany Biosciences Shingles Treatments Introduction
11.6.4 Epiphany Biosciences Revenue in Shingles Treatments Business (2019-2024)
11.6.5 Epiphany Biosciences Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Shingles Treatments Introduction
11.7.4 Merck Revenue in Shingles Treatments Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Beijing Minhai Biotechnology
11.8.1 Beijing Minhai Biotechnology Company Detail
11.8.2 Beijing Minhai Biotechnology Business Overview
11.8.3 Beijing Minhai Biotechnology Shingles Treatments Introduction
11.8.4 Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2019-2024)
11.8.5 Beijing Minhai Biotechnology Recent Development
11.9 GeneOne Life Science
11.9.1 GeneOne Life Science Company Detail
11.9.2 GeneOne Life Science Business Overview
11.9.3 GeneOne Life Science Shingles Treatments Introduction
11.9.4 GeneOne Life Science Revenue in Shingles Treatments Business (2019-2024)
11.9.5 GeneOne Life Science Recent Development
11.10 NAL Pharmaceuticals
11.10.1 NAL Pharmaceuticals Company Detail
11.10.2 NAL Pharmaceuticals Business Overview
11.10.3 NAL Pharmaceuticals Shingles Treatments Introduction
11.10.4 NAL Pharmaceuticals Revenue in Shingles Treatments Business (2019-2024)
11.10.5 NAL Pharmaceuticals Recent Development
11.11 TSRL
11.11.1 TSRL Company Detail
11.11.2 TSRL Business Overview
11.11.3 TSRL Shingles Treatments Introduction
11.11.4 TSRL Revenue in Shingles Treatments Business (2019-2024)
11.11.5 TSRL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
